DK1776587T3 - Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf - Google Patents

Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf

Info

Publication number
DK1776587T3
DK1776587T3 DK05772471T DK05772471T DK1776587T3 DK 1776587 T3 DK1776587 T3 DK 1776587T3 DK 05772471 T DK05772471 T DK 05772471T DK 05772471 T DK05772471 T DK 05772471T DK 1776587 T3 DK1776587 T3 DK 1776587T3
Authority
DK
Denmark
Prior art keywords
colorectal
carcinoma
colorectal adenoma
biomarker
adenoma
Prior art date
Application number
DK05772471T
Other languages
English (en)
Inventor
Kerstin David
Anne-Kristin Fentz
Hartmut Juhl
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1776587(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Application granted granted Critical
Publication of DK1776587T3 publication Critical patent/DK1776587T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
DK05772471T 2004-08-13 2005-08-11 Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf DK1776587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
PCT/EP2005/008742 WO2006053592A1 (en) 2004-08-13 2005-08-11 Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same

Publications (1)

Publication Number Publication Date
DK1776587T3 true DK1776587T3 (da) 2009-04-20

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04764118T DK1761779T3 (da) 2004-08-13 2004-08-13 Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem
DK05772471T DK1776587T3 (da) 2004-08-13 2005-08-11 Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04764118T DK1761779T3 (da) 2004-08-13 2004-08-13 Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem

Country Status (20)

Country Link
US (2) US7951528B2 (da)
EP (3) EP1843159A1 (da)
JP (2) JP4916441B2 (da)
KR (1) KR20070051328A (da)
CN (2) CN101014859A (da)
AT (2) ATE376674T1 (da)
AU (2) AU2004322162B2 (da)
BR (1) BRPI0419002A (da)
CA (2) CA2577601A1 (da)
DE (2) DE602004009716T2 (da)
DK (2) DK1761779T3 (da)
ES (2) ES2295907T3 (da)
IL (2) IL181131A (da)
MX (2) MX2007001479A (da)
NO (2) NO20070599L (da)
PL (2) PL1761779T3 (da)
PT (2) PT1761779E (da)
SI (1) SI1776587T1 (da)
WO (2) WO2006015616A1 (da)
ZA (1) ZA200701188B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4916441B2 (ja) 2004-08-13 2012-04-11 インディヴュームド ゲゼルシャフト ミット ベシュレンクテル ハフツング 結腸直腸腺腫及び／又は癌腫に対するバイオマーカーとしてのトランスサイレチンの使用；検出方法及び試験システム
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
WO2009025080A1 (ja) * 2007-08-18 2009-02-26 School Juridical Person Kitasato Institute 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
EP2926138A4 (en) * 2012-11-30 2016-09-14 Applied Proteomics Inc METHOD FOR ASSESSING THE PRESENCE OR RISK OF COLON TUMORS
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
SG11201608053PA (en) * 2014-03-28 2016-10-28 Applied Proteomics Inc Protein biomarker profiles for detecting colorectal tumors
CN107110865B (zh) * 2014-08-22 2020-01-10 雅培制药有限公司 用于结肠直肠癌的早期检测的方法
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
JP2018517892A (ja) 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
US20020160394A1 (en) 2001-01-24 2002-10-31 Bayer Corporation Regulation of transthyretin to treat obesity
AU2002316299A1 (en) 2001-06-22 2003-01-08 Merck And Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
AU2002349786A1 (en) 2002-06-19 2004-01-06 Japan As Represented By The President Of The University Of Tokyo Method for diagnosis of colorectal tumors
NZ562192A (en) * 2002-08-06 2009-07-31 Ciphergen Biosystems Inc Use of biomarkers for detecting ovarian cancer
US20070117164A1 (en) * 2003-04-08 2007-05-24 Raskov Hans H Method for detection of colorectal cancer in human samples
WO2005008251A2 (en) * 2003-07-11 2005-01-27 Praecis Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
CN101052727B (zh) 2004-08-13 2011-04-20 艾格麦迪卡技术有限公司 用于测定生理或水性液体中被分析物浓度的被分析物测试系统
JP4916441B2 (ja) 2004-08-13 2012-04-11 インディヴュームド ゲゼルシャフト ミット ベシュレンクテル ハフツング 結腸直腸腺腫及び／又は癌腫に対するバイオマーカーとしてのトランスサイレチンの使用；検出方法及び試験システム
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
SI1776587T1 (sl) 2009-06-30
IL181131A0 (en) 2007-07-04
CN101014861A (zh) 2007-08-08
NO20070599L (no) 2007-05-14
DE602005012108D1 (de) 2009-02-12
CA2576998A1 (en) 2006-05-26
JP2008509407A (ja) 2008-03-27
EP1776587A1 (en) 2007-04-25
AU2004322162A1 (en) 2006-02-16
US20070184499A1 (en) 2007-08-09
WO2006053592A1 (en) 2006-05-26
ATE419534T1 (de) 2009-01-15
BRPI0419002A (pt) 2007-12-11
CN101014859A (zh) 2007-08-08
EP1776587B9 (en) 2009-09-16
AU2005306103A1 (en) 2006-05-26
MX2007001479A (es) 2007-07-25
PT1776587E (pt) 2009-04-03
EP1776587B1 (en) 2008-12-31
IL181131A (en) 2011-03-31
US20080160515A1 (en) 2008-07-03
PL1776587T3 (pl) 2009-06-30
PT1761779E (pt) 2008-02-01
US7951528B2 (en) 2011-05-31
AU2004322162A2 (en) 2006-02-16
EP1761779B1 (en) 2007-10-24
ATE376674T1 (de) 2007-11-15
PL1761779T3 (pl) 2008-04-30
DK1761779T3 (da) 2008-02-25
ZA200701188B (en) 2009-01-28
US7883842B2 (en) 2011-02-08
JP4916441B2 (ja) 2012-04-11
IL181132A0 (en) 2007-07-04
MX2007001254A (es) 2007-10-05
JP4592753B2 (ja) 2010-12-08
WO2006015616A1 (en) 2006-02-16
EP1843159A1 (en) 2007-10-10
IL181132A (en) 2011-04-28
NO20070598L (no) 2007-05-14
AU2004322162B2 (en) 2011-04-28
ES2322378T3 (es) 2009-06-19
CA2577601A1 (en) 2006-02-16
DE602004009716T2 (de) 2008-08-28
EP1761779A1 (en) 2007-03-14
ES2295907T3 (es) 2008-04-16
JP2008509409A (ja) 2008-03-27
DE602004009716D1 (de) 2007-12-06
KR20070051328A (ko) 2007-05-17

Similar Documents

Publication Publication Date Title
DK1776587T3 (da) Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf
ATE527543T1 (de) Testvorrichtung zur schnelldiagnose
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
WO2008095152A3 (en) Methods and materials for identifying the origin of a carcinoma of unknown primary origin
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2009058902A3 (en) Methods and devices for analyte detection
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
AR058900A1 (es) Metodo para determinar la identidad o no identidad y la concentracion de un compuesto quimico en un medio
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
NO20062280L (no) Test
NO20080510L (no) Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon
CY1113013T1 (el) Βελτιωμενες μεθοδοι ανοσολογικων δοκιμασιων
WO2007062142A3 (en) Method for identifying biomarkers associated with cancer
WO2009063249A3 (en) Early detection of sepsis
WO2012045324A8 (en) Method for detecting a parkinson's disease and test system
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
WO2004097030A3 (en) Prognostic breast cancer biomarkers
WO2022204378A3 (en) Identification of rna biomarkers in colorectal cancer
EP2017642A3 (fr) Procédé et dispositif de détection et de mesure de paramètres de signaux radioélectriques
MX2017008959A (es) Biomarcadores relacionados con la funcion del riñon y metodos que involucran su uso.
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal